Literature DB >> 27032828

The non-small-cell lung cancer drug market.

Khurram Nawaz1, Rachel M Webster1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27032828     DOI： 10.1038/nrd.2016.42

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  13 in total

1.  Multiomics Reveals Ectopic ATP Synthase Blockade Induces Cancer Cell Death via a lncRNA-mediated Phospho-signaling Network.

Authors:  Yi-Wen Chang; Chia-Lang Hsu; Cheng-Wei Tang; Xiang-Jun Chen; Hsuan-Cheng Huang; Hsueh-Fen Juan
Journal:  Mol Cell Proteomics       Date:  2020-08-11       Impact factor: 5.911

Review 2.  The emergence of nanoporous materials in lung cancer therapy.

Authors:  Deepika Radhakrishnan; Shan Mohanan; Goeun Choi; Jin-Ho Choy; Steffi Tiburcius; Hoang Trung Trinh; Shankar Bolan; Nikki Verrills; Pradeep Tanwar; Ajay Karakoti; Ajayan Vinu
Journal:  Sci Technol Adv Mater       Date:  2022-07-20       Impact factor: 7.821

3.  [Cell Cycle Checkpoint Kinase and Drug Resistance of Lung Cancer].

Authors:  Zhiyin Ke; Ailing Liang; Yongjun Liu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2021-04-20

4.  Implications of the Adiponectin System in Non-Small Cell Lung Cancer Patients: A Case-Control Study.

Authors:  Ersilia Nigro; Fabio Perrotta; Maria Ludovica Monaco; Rita Polito; Pia Clara Pafundi; Maria Gabriella Matera; Aurora Daniele; Andrea Bianco
Journal:  Biomolecules       Date:  2020-06-18

5.  Targeted chemotherapy for subcutaneous and orthotopic non-small cell lung tumors with cyclic RGD-functionalized and disulfide-crosslinked polymersomal doxorubicin.

Authors:  Yan Zou; Jingjing Wei; Yifeng Xia; Fenghua Meng; Jiandong Yuan; Zhiyuan Zhong
Journal:  Signal Transduct Target Ther       Date:  2018-12-14

6.  Validating a targeted next-generation sequencing assay and profiling somatic variants in Chinese non-small cell lung cancer patients.

Authors:  Ruirui Jiang; Bo Zhang; Xiaodong Teng; Peizhen Hu; Sanpeng Xu; Zuyu Zheng; Rui Liu; Tingdong Tang; Feng Ye
Journal:  Sci Rep       Date:  2020-02-07       Impact factor: 4.379

7.  Knockdown of LncRNA LINC00958 Inhibits the Proliferation and Migration of NSCLC Cells by MiR-204-3p/KIF2A Axis.

Authors:  Qing Wang; Kai Li; Xiaoliang Li
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

8.  Orally available tubulin inhibitor VERU-111 enhances antitumor efficacy in paclitaxel-resistant lung cancer.

Authors:  Foyez Mahmud; Shanshan Deng; Hao Chen; Duane D Miller; Wei Li
Journal:  Cancer Lett       Date:  2020-09-11       Impact factor: 9.756

9.  Apigenin potentiates TRAIL therapy of non-small cell lung cancer via upregulating DR4/DR5 expression in a p53-dependent manner.

Authors:  Minghui Chen; Xueshi Wang; Daolong Zha; Fangfang Cai; Wenjing Zhang; Yan He; Qilai Huang; Hongqin Zhuang; Zi-Chun Hua
Journal:  Sci Rep       Date:  2016-10-18       Impact factor: 4.379

10.  Proscillaridin A induces apoptosis and suppresses non-small-cell lung cancer tumor growth via calcium-induced DR4 upregulation.

Authors:  Run-Ze Li; Xing-Xing Fan; Fu-Gang Duan; Ze-Bo Jiang; Hu-Dan Pan; Lian-Xiang Luo; Yan-Ling Zhou; Ying Li; Ying-Jia Yao; Xiao-Jun Yao; Elaine Lai-Han Leung; Liang Liu
Journal:  Cell Death Dis       Date:  2018-06-13       Impact factor: 8.469
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.